Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-067472
Filing Date
2025-07-11
Accepted
2025-07-11 18:20:44
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2520705-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2520705-1_3seq1.xml 3 5656
2 EXHIBIT 24 tm2520705d1_ex24.htm EX-24 4619
  Complete submission text file 0001104659-25-067472.txt   11961
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Reporting) CIK: 0001551152 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 251119861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)